advertisement
Lincke JB 11
Showing records 1 to 11 |
Display all abstracts from Lincke JB117581 PRESERFLO MicroShunt implantation versus trabeculectomy for primary open-angle glaucoma: a two-year follow-up studyGubser PA; Gubser PA
Eye and vision (London, England) 2023; 10: 50
117481 Functional and Morphological Outcomes after Trabeculectomy and Deep Sclerectomy-Results from a Monocentric Registry StudyPfeiffer V; Pfeiffer V; Gubser PA
Diagnostics (Basel, Switzerland) 2024; 14:
117581 PRESERFLO MicroShunt implantation versus trabeculectomy for primary open-angle glaucoma: a two-year follow-up studyPfeiffer V; Pfeiffer V
Eye and vision (London, England) 2023; 10: 50
117481 Functional and Morphological Outcomes after Trabeculectomy and Deep Sclerectomy-Results from a Monocentric Registry StudyGubser PA; Shang X
Diagnostics (Basel, Switzerland) 2024; 14:
117581 PRESERFLO MicroShunt implantation versus trabeculectomy for primary open-angle glaucoma: a two-year follow-up studyHug S; Shang X
Eye and vision (London, England) 2023; 10: 50
117481 Functional and Morphological Outcomes after Trabeculectomy and Deep Sclerectomy-Results from a Monocentric Registry StudyLincke JB
Diagnostics (Basel, Switzerland) 2024; 14:
117581 PRESERFLO MicroShunt implantation versus trabeculectomy for primary open-angle glaucoma: a two-year follow-up studyLincke JB
Eye and vision (London, England) 2023; 10: 50
117481 Functional and Morphological Outcomes after Trabeculectomy and Deep Sclerectomy-Results from a Monocentric Registry StudyHäner NU; Zinkernagel MS
Diagnostics (Basel, Switzerland) 2024; 14:
117581 PRESERFLO MicroShunt implantation versus trabeculectomy for primary open-angle glaucoma: a two-year follow-up studyHäner NU
Eye and vision (London, England) 2023; 10: 50
117481 Functional and Morphological Outcomes after Trabeculectomy and Deep Sclerectomy-Results from a Monocentric Registry StudyUnterlauft JD
Diagnostics (Basel, Switzerland) 2024; 14:
117581 PRESERFLO MicroShunt implantation versus trabeculectomy for primary open-angle glaucoma: a two-year follow-up studyZinkernagel MS; Unterlauft JD
Eye and vision (London, England) 2023; 10: 50